Colorectal screening now available at participating Ky. pharmaciesHealthy Care

L-R: Brooke Sorgi of Exact Sciences, maker of Cologuard, a

DNA-based screening test, and Capital Pharmacy pharmacist

Dr. Emily Wilkerson mark the first pharmacist-led colorectal

cancer screening via a stool-based test on Sept. 29.

Kentucky's pharmacists and health insurers have teamed up to offer what they say is the nation's first "pharmacist-led colorectal cancer screening via a non-invasive stool-based test."

The test was done Sept. 29 at Capital Pharmacy & Medical Equipment in Frankfort, the Kentucky Pharmacists Association and the Kentucky Association of Health Plans said in a Nov. 17 news release.

“Health plans and pharmacists are joining together to tackle a leading cause of death in the commonwealth,” KAHP Executive Director Tom Stephens said.

KAHP gave the Kentucky Pharmacists Education and Research Foundation a $50,000 grant to expand access to these screenings in Kentucky. Participating pharmacies are being reimbursed for pharmacist-led screening and follow-up.  

KPA Executive Director Ben Mudd said, “Adding assessment of and screening for colorectal cancer to existing pharmacy protocols can greatly impact our two-decade-long fight to increase CRC screening rates. With early detection, colorectal cancer is a preventable, treatable, and beatable disease.”

The screenings were authorized by a new protocol approved by the Kentucky Board of Pharmacy in September 2021. It lets pharmacists initiate dispensing of noninvasive, stool-based colorectal cancer screening such as a fecal immunochemical test or a stool DNA test. Pharmacies interested in providing the service can contact Dr. Emily Wilkerson at fellow@kphanet.org for more information.

from KENTUCKY HEALTH NEWS https://ift.tt/BGCTy9h Colorectal screening now available at participating Ky. pharmaciesHealthy Care